We are live on ! Find out more
GCM

Gallacher Capital Management Portfolio holdings

AUM $178M
1-Year Est. Return 29.29%
This Fund
S&P 500
This Quarter Est. Return
+6.55%
1 Year Est. Return
+29.29%
3 Year Est. Return
+70.74%
5 Year Est. Return
10 Year Est. Return
AUM
$165M
AUM Growth
Cap. Flow
+$169M
Cap. Flow %
102.16%
Top 10 Hldgs %
38.47%
Holding
230
New
230
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 13.5%
2 Consumer Staples 12.79%
3 Consumer Discretionary 8.62%
4 Technology 7.2%
5 Financials 5.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBP icon
226
First Bancorp
FBP
$4.44B
$132K 0.08%
+10,353
New +$151K
VGR
227
DELISTED
Vector Group Ltd.
VGR
$128K 0.08%
+10,789
New +$114K
SXC icon
228
SunCoke Energy
SXC
$788M
$121K 0.07%
+13,985
New +$108K
CION icon
229
CION Investment
CION
$374M
$117K 0.07%
+12,004
New +$117K
FLNA
230
CALL
Filana Therapeutics
FLNA
$47.3M
$26.2K 0.02%
+50,100
New +$1.8M

Similar funds

Gallacher Capital Management's Q4 2022 Portfolio in Review

Q4 2022 is the first quarter with a 13F filing on record for Gallacher Capital Management, which disclosed 230 positions worth $165M. Its ten largest holdings account for 38% of the portfolio.

Its largest position is Filana Therapeutics: 588,533 shares worth $17.4M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, followed by Consumer Staples and Consumer Discretionary.

  • Gallacher Capital Management's largest Q4 2022 buy was Filana Therapeutics: 588,533 shares worth $17.4M.
  • Gallacher Capital Management's ten largest holdings make up 38% of its $165M portfolio in Q4 2022.
  • Gallacher Capital Management disclosed 230 positions in Q4 2022, its first 13F filing on record.

Based on Gallacher Capital Management's 13F filing for Q4 2022, filed 17 Jan 2023.